Edwards Lifesciences Corp.'s Intuity Elite rapid-deployment aortic valve replacement is now commercially available in the US. FDA approved the device based on clinical data showing it may reduce cross-clamp time and cardiopulmonary bypass time compared totraditional aortic valve replacement surgery.
The agency approved the Intuity Elite bioprosthesis on August 12 for a broad indication: The replacement of diseased, damaged, or malfunctioning native or prosthetic aortic
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?